Laboratory Optimization Tweaks for Sanger Sequencing in a Resource-Limited Setting
AuthorOnwuamah, Chika K
Okwuraiwe, Azuka P
Ahmed, Rahaman A
Sokei, Judith O
Okoli, Leona C
Kagurusi, Brian A
JournalJournal of Biomolecular Techniques : JBT
PublisherAssociation of Biomolecular Resource Facilities
MetadataShow full item record
AbstractDespite various challenges that hinder the implementation of high-tech molecular methods in resource-limited settings, we have been able to implement and achieve International Organization for Standardization 15189:2012 accreditation for genotypic HIV drug resistance testing in our facility. At the Center for Human Virology and Genomics, Nigerian Institute of Medical Research, Nigeria has recorded a high sequencing success rate and good quality sequence data. This was achieved by optimizing laboratory processes from 2008 to the current date. We have optimized sample preparation, RT-PCR, several post-PCR processes, and the cycle sequencing to improve the sensitivity of amplification even with limited plasma samples and low viral copy numbers. The optimized workflow maximizes output, minimizes reagent wastage, and achieves substantial cost savings without compromising the quality of the sequence data. Our performance at our last external quality assurance program is a testimonial to the efficiency of the workflow. For the 5-sample panel, each with 67–68 mutation points evaluated, we scored 100% for all 5 specimens. Our optimized laboratory workflow is thus documented to support laboratories and to help researchers achieve excellent results the first time and eliminate contamination while minimizing the wastage of costly sequencing reagents.
Rights/Terms© Association of Biomolecular Resource Facilities.
HIV drug resistance
reverse transcriptase polymerase chain reaction
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/14217
- Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performance.
- Authors: Descamps D, Delaugerre C, Masquelier B, Ruffault A, Marcelin AG, Izopet J, Chaix ML, Calvez V, Brun-Vézinet F, Costagliola D
- Issue date: 2006 Feb
- Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations.
- Authors: Ávila-Ríos S, Parkin N, Swanstrom R, Paredes R, Shafer R, Ji H, Kantor R
- Issue date: 2020 Jun 5
- A Robust PCR Protocol for HIV Drug Resistance Testing on Low-Level Viremia Samples.
- Authors: Gupta S, Taylor T, Patterson A, Liang B, Bullard J, Sandstrom P, Van Domselaar G, Ji H
- Issue date: 2017
- HIV contamination of commercial PCR enzymes raises the importance of quality control of low-cost in-house genotypic HIV drug resistance tests.
- Authors: Monleau M, Plantier JC, Peeters M
- Issue date: 2010
- Performance evaluation of a laboratory developed PCR test for quantitation of HIV-2 viral RNA.
- Authors: Jagodzinski LL, Manak MM, Hack HR, Liu Y, Peel SA
- Issue date: 2020